DXCM
Price
$82.93
Change
-$0.65 (-0.78%)
Updated
Jul 3 closing price
Capitalization
53.47B
25 days until earnings call
KLYG
Price
$0.10
Change
-$0.02 (-16.67%)
Updated
Jul 3 closing price
Capitalization
2.05M
Interact to see
Advertisement

DXCM vs KLYG

Header iconDXCM vs KLYG Comparison
Open Charts DXCM vs KLYGBanner chart's image
DexCom
Price$82.93
Change-$0.65 (-0.78%)
Volume$1.84M
Capitalization53.47B
Kelyniam Global
Price$0.10
Change-$0.02 (-16.67%)
Volume$28K
Capitalization2.05M
DXCM vs KLYG Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLYG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. KLYG commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and KLYG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (DXCM: $82.93 vs. KLYG: $0.10)
Brand notoriety: DXCM and KLYG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 50% vs. KLYG: 104%
Market capitalization -- DXCM: $53.47B vs. KLYG: $2.05M
DXCM [@Medical Specialties] is valued at $53.47B. KLYG’s [@Medical Specialties] market capitalization is $2.05M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 0 FA rating(s) are green whileKLYG’s FA Score has 2 green FA rating(s).

  • DXCM’s FA Score: 0 green, 5 red.
  • KLYG’s FA Score: 2 green, 3 red.
According to our system of comparison, KLYG is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 5 TA indicator(s) are bullish while KLYG’s TA Score has 3 bullish TA indicator(s).

  • DXCM’s TA Score: 5 bullish, 3 bearish.
  • KLYG’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, DXCM is a better buy in the short-term than KLYG.

Price Growth

DXCM (@Medical Specialties) experienced а -2.07% price change this week, while KLYG (@Medical Specialties) price change was -13.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

DXCM is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($53.5B) has a higher market cap than KLYG($2.05M). DXCM YTD gains are higher at: 6.635 vs. KLYG (-41.176).
DXCMKLYGDXCM / KLYG
Capitalization53.5B2.05M2,609,756%
EBITDA917MN/A-
Gain YTD6.635-41.176-16%
P/E Ratio106.11N/A-
Revenue3.62BN/A-
Total Cash2.72BN/A-
Total Debt2.59BN/A-
FUNDAMENTALS RATINGS
DXCM vs KLYG: Fundamental Ratings
DXCM
KLYG
OUTLOOK RATING
1..100
6350
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
413
PRICE GROWTH RATING
1..100
5365
P/E GROWTH RATING
1..100
727
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KLYG's Valuation (74) in the null industry is in the same range as DXCM (83) in the Medical Specialties industry. This means that KLYG’s stock grew similarly to DXCM’s over the last 12 months.

KLYG's Profit vs Risk Rating (90) in the null industry is in the same range as DXCM (100) in the Medical Specialties industry. This means that KLYG’s stock grew similarly to DXCM’s over the last 12 months.

KLYG's SMR Rating (3) in the null industry is somewhat better than the same rating for DXCM (41) in the Medical Specialties industry. This means that KLYG’s stock grew somewhat faster than DXCM’s over the last 12 months.

DXCM's Price Growth Rating (53) in the Medical Specialties industry is in the same range as KLYG (65) in the null industry. This means that DXCM’s stock grew similarly to KLYG’s over the last 12 months.

KLYG's P/E Growth Rating (7) in the null industry is somewhat better than the same rating for DXCM (72) in the Medical Specialties industry. This means that KLYG’s stock grew somewhat faster than DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMKLYG
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 16 days ago
71%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLYG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IDEV76.240.12
+0.16%
iShares Core MSCI Intl Dev Mkts ETF
AIA81.640.02
+0.02%
iShares Asia 50 ETF
HYFI37.37-0.03
-0.07%
AB High Yield ETF
BITU53.12-0.35
-0.65%
ProShares Ultra Bitcoin ETF
NVDQ1.34-0.04
-2.55%
T-REX 2X Inverse NVIDIA Daily Target ETF

DXCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with RMD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then RMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DXCM
1D Price
Change %
DXCM100%
-0.78%
RMD - DXCM
35%
Loosely correlated
+0.42%
BAX - DXCM
35%
Loosely correlated
-0.39%
IRMD - DXCM
34%
Loosely correlated
+0.42%
MDT - DXCM
33%
Loosely correlated
-0.41%
PEN - DXCM
33%
Poorly correlated
+0.53%
More

KLYG and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLYG has been loosely correlated with OSSUY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if KLYG jumps, then OSSUY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLYG
1D Price
Change %
KLYG100%
-13.04%
OSSUY - KLYG
34%
Loosely correlated
N/A
DXCM - KLYG
22%
Poorly correlated
-0.78%
EMITF - KLYG
21%
Poorly correlated
N/A
POAI - KLYG
21%
Poorly correlated
+1.89%
MBGNF - KLYG
3%
Poorly correlated
N/A
More